Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma

Journal article

Open access

Peer reviewed

Nancy S. Younis, Amal M. H. Ghanim and Sameh Saber

Scientific reports, Vol.12(1), pp.13607-13607

10/08/2022

PMID: 35948610

Abstract

Author

url

https://doi.org/10.1038/s41598-022-17580-7View

Published (Version of record) Open

1 Record Views

Title: Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
Creators - without role: Nancy S. Younis - King Faisal University
Amal M. H. Ghanim - Delta University for Science and Technology
Sameh Saber - Delta University for Science and Technology
Publication Details: Scientific reports, Vol.12(1), pp.13607-13607
Publisher: Nature Publishing Group UK
Identifiers: 9919535508331
Academic Unit: King Faisal University
Language: English
Resource Type: Journal article